サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1402760

アジア太平洋地域のオルガノイド市場の2030年までの予測-地域別分析：臓器タイプ別、用途別、供給源別、タイプ別

Asia Pacific Organoids Market Forecast to 2030 - Regional Analysis - by Organ Type, Application, Source, and Type

出版日
ページ情報
英文 98 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.64円
アジア太平洋地域のオルガノイド市場の2030年までの予測-地域別分析：臓器タイプ別、用途別、供給源別、タイプ別
出版日: 2023年11月20日
発行: The Insight Partners
ページ情報: 英文 98 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

アジア太平洋地域のオルガノイド市場は、2022年の3億4,124万米ドルから2030年には18億6,632万米ドルに成長すると予測されています。2022年から2030年までのCAGRは23.7%と推定されます。

創薬活動がアジア太平洋地域のオルガノイド市場を後押し

新薬・先端薬への需要の高まりが、創薬・研究全体のペースを押し上げています。ClinicalTrials.govによると、2020年の臨床試験総数は356,282件と推定されています。Hubrecht研究所の最近の調査によると、オルガノイドは、薬剤の恩恵を受けそうにない患者を特定することで、高価な薬剤の費用対効果を高める可能性があるとしています。世界の臨床試験の増加は、オルガノイドモデルを含む先端医療技術の需要を促進すると予想されています。

さらに、創薬におけるオルガノイドはがんだけに限らず、嚢胞性線維症、多発性嚢胞腎、小頭症、腸や気道の感染症など、他の疾患でも使用されています。例えば、オルガノイドは臓器の構造や機能など、臓器の特性を要約することができます。また、オルガノイドは組織や臓器の本来の遺伝的・エピジェネティックな状態を復元できるため、遺伝子編集に適しています。様々な研究が、CRISPR-Cas9技術とオルガノイドの組み合わせによる良好な結果を示しており、嚢胞性線維症におけるブレークスルーの機会を広げています。2020年に発表された研究「CRISPR-Based Adenine Editors Correct Nonsense Mutation in a Cystic Fibrosis Organoid Biobank」によると、嚢胞性線維症腸管オルガノイドのバイオバンクは664人の患者を代表し、そのうちの～20％がアデニン塩基エディターによって嚢胞性線維症膜貫通型伝導体受容体のナンセンス変異を理論的に効率よく修復することができました。いくつかの動物モデルで遺伝子編集オルガノイドの成果はあるもの、その効率は著しく低く、成功率は高くないです。したがって、遺伝子編集オルガノイドの安全性、長期安定性、機能性のためのプロセスの研究開発は極めて重要です。

さらに、COVID-19のパンデミックは、ヒト肺オルガノイドモデルを開発する必要性を引き起こしました。例えば、ミリポア・シグマ社は3dGROヒト肺オルガノイド培養システムを開発しました。このシステムは、研究者がヒト肺上皮のオルガノイドモデルを培養するための臓器組織を制御し、アクセスし、再現することを可能にし、研究中に肯定的で成功した結果を得るのに役立ちます。したがって、このような技術革新は市場成長にとってより大きな成長機会を提供すると期待されます。

アジア太平洋地域のオルガノイド市場概要

アジア太平洋地域のオルガノイド市場は、オーストラリア、中国、インド、日本、韓国、その他アジア太平洋地域に区分されます。同地域の市場は、がん罹患率の増加、遺伝子変異およびがん研究に対する需要の増加、ヒトオルガノイドに関連する認識を高めるための政府の取り組み、先進的なヒトオルガノイド製品の研究開発と商業化のための支援規制、オルガノイド研究に対する資金提供の増加などの要因により、予測期間中最も速い速度で成長し続ける可能性が高いです。

アジア太平洋地域のオルガノイド市場の収益と2030年までの予測（金額）

アジア太平洋地域のオルガノイド市場のセグメンテーション

アジア太平洋地域のオルガノイド市場は、臓器タイプ、用途、供給源、国に区分されます。

臓器タイプに基づき、アジア太平洋地域のオルガノイド市場は腸、肝臓、胃、膵臓、肺、脳、腎臓、その他に区分されます。2022年のアジア太平洋地域のオルガノイド市場では、腸セグメントが最大のシェアを占めています。

タイプ別では、アジア太平洋地域のオルガノイド市場は機器、消耗品、サービスに区分されます。消耗品セグメントは、2022年のアジア太平洋地域のオルガノイド市場で最大のシェアを占めました。

用途別では、アジア太平洋地域のオルガノイド市場は発生生物学、感染症の疾患病状、再生医療、薬物毒性・有効性試験、創薬・個別化医療、その他に区分されます。2022年のアジア太平洋地域のオルガノイド市場では、発生生物学セグメントが最大のシェアを占めています。

供給源に基づいて、アジア太平洋地域のオルガノイド市場は多能性幹細胞と臓器特異的成体幹細胞に二分されます。2022年のアジア太平洋地域のオルガノイド市場では、多能性幹細胞分野が大きなシェアを占めています。

国別に見ると、アジア太平洋地域のオルガノイド市場は、日本、中国、オーストラリア、インド、韓国、その他アジア太平洋地域に区分されます。2022年のアジア太平洋地域のオルガノイド市場は日本が独占しています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • アジア太平洋地域の主要洞察
  • アジア太平洋地域市場の魅力

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 アジア太平洋地域のオルガノイド市場情勢

  • 概観
  • アジア太平洋地域のPEST分析

第5章 アジア太平洋地域のオルガノイド市場：主要産業力学

  • 主な市場促進要因
    • 腫瘍モデリングとバイオバンクの需要増加
    • 個別化医薬品の採用拡大
    • 動物実験モデルの代替品開発への注目の高まり
  • 主な市場抑制要因
    • 既存のワークフローへのオルガノイドの組み込みに関する問題
    • 熟練した専門家の不足
  • 主な市場機会
    • 創薬活動の重視
  • 今後の動向
    • オルガノイドとOrgan-On-A-Chipの組み合わせ
  • インパクト分析

第6章 オルガノイド市場：アジア太平洋地域の市場分析

  • アジア太平洋地域のオルガノイド市場の収益、2022年～2030年

第7章 アジア太平洋地域のオルガノイド市場-2030年までの収益と予測：臓器タイプ別

  • アジア太平洋地域のオルガノイド市場の収益シェア：臓器タイプ別、2022年・2030年（%）
  • 胃
  • 腸
  • 肝臓
  • 膵臓
  • 肺
  • 脳
  • 腎臓
  • その他

第8章 アジア太平洋地域のオルガノイド市場-2030年までの収益と予測：用途別

  • アジア太平洋地域のオルガノイド市場の収益シェア：用途別、2022年・2030年（%）
  • 発生生物学
  • 感染症の疾患病状
  • 再生医療
  • 薬物毒性・有効性試験
  • 創薬・個別化医療
  • その他

第9章 アジア太平洋地域のオルガノイド市場-2030年までの収益と予測：供給源別

  • アジア太平洋地域のオルガノイド市場の収益シェア：供給源別、2022年・2030年（%）
  • 多能性幹細胞
  • 臓器特異的成体幹細胞

第10章 アジア太平洋地域のオルガノイド市場-2030年までの収益と予測：タイプ別

  • アジア太平洋地域のオルガノイド市場の収益シェア：タイプ別、2022年・2030年（%）
  • 機器
  • 消耗品
  • サービス

第11章 アジア太平洋地域のオルガノイド市場：国別分析

第12章 COVID-19前後の影響

  • COVID-19前後の影響

第13章 アジア太平洋地域のオルガノイド市場：業界情勢

  • 市場参入企業の成長戦略（%）
  • 有機的発展
  • 無機的発展

第14章 アジア太平洋地域のオルガノイド市場：主要企業プロファイル

  • STEMCELL Technologies Inc.
  • Cellesce Ltd
  • Thermo Fisher Scientific Inc
  • Corning Inc
  • Merck KGaA
  • InSphero

第15章 付録

図表

List Of Tables

  • Table 1. Asia Pacific Organoids Market Segmentation
  • Table 2. China Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Organ Type
  • Table 3. China Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 4. China Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Source
  • Table 5. China Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Type
  • Table 6. Japan Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Organ Type
  • Table 7. Japan Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 8. Japan Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Source
  • Table 9. Japan Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Type
  • Table 10. India Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Organ Type
  • Table 11. India Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 12. India Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Source
  • Table 13. India Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Type
  • Table 14. Australia Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Organ Type
  • Table 15. Australia Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 16. Australia Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Source
  • Table 17. Australia Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Type
  • Table 18. South Korea Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Organ Type
  • Table 19. South Korea Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 20. South Korea Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Source
  • Table 21. South Korea Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Type
  • Table 22. Rest of Asia Pacific Organoids Market Revenue and Forecast to 2030 (US$ Mn) -Organ Type
  • Table 23. Rest of Asia Pacific Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 24. Rest of Asia Pacific Organoids Market Revenue and Forecast to 2030 (US$ Mn) Source
  • Table 25. Rest of Asia Pacific Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Type
  • Table 26. Organic Developments Done by Companies
  • Table 27. Inorganic Developments Done by Companies
  • Table 28. Glossary of Terms, Asia Pacific Organoids Market

List Of Figures

  • Figure 1. Asia Pacific Organoids Market Segmentation, By Country
  • Figure 2. Asia Pacific - PEST Analysis
  • Figure 3. Asia Pacific Organoids Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. Asia Pacific Organoids Market Revenue (US$ Mn), 2022 - 2030
  • Figure 6. Asia Pacific Organoids Market Revenue Share, by Organ Type 2022 & 2030 (%)
  • Figure 7. Stomach: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Intestine: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Liver: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Pancreas: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Lung: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Brain: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Kidney: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Others: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Asia Pacific Organoids Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 16. Developmental Biology: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Disease Pathology of Infectious Disease: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Regenerative Medicine: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Drug Toxicity and Efficacy Testing: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Drug Discovery and Personalized Medicine: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Others: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Asia Pacific Organoids Market Revenue Share, by Source 2022 & 2030 (%)
  • Figure 23. Pluripotent Stem Cells: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Organ-specific Adult Stem Cells: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Asia Pacific Organoids Market Revenue Share, by Type 2022 & 2030 (%)
  • Figure 26. Instruments: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Consumables: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Services: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. Asia Pacific Organoids Market, By Country -Revenue (2022) ($Mn)
  • Figure 30. Asia Pacific Organoids Market, By Key Countries, 2022 And 2030 (%)
  • Figure 31. China Organoids Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 32. Japan Organoids Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 33. India Organoids Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 34. Australia Organoids Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 35. South Korea Organoids Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 36. Rest of Asia Pacific Organoids Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 37. Pre & Post COVID-19 Impact
  • Figure 38. Growth Strategies Done by the Companies in the Market, (%)
目次
Product Code: TIPRE00018852

The Asia Pacific organoids market is expected to grow from US$ 341.24 million in 2022 to US$ 1,866.32 million by 2030. It is estimated to grow at a CAGR of 23.7% from 2022 to 2030.

Focus on Drug Discovery Activities Fuel the Asia Pacific Organoids Market

The increasing demand for new and advanced drugs is driving the overall pace of drug discovery and research. According to ClinicalTrials.gov, the total number of clinical trial studies in 2020 was estimated to be 356,282. A recent survey by the Hubrecht Institute states that organoids can potentially make expensive drugs more cost-effective by identifying patients who are not likely to benefit from the drug. An increasing number of clinical trials worldwide is expected to drive the demand for advanced medical technologies, including organoid models.

Further, organoids in drug discovery are not limited to just cancer, they are also used in other diseases, such as cystic fibrosis, polycystic kidney disease, microcephaly, and infectious diseases of the gut and airway. For instance, organoids can summarize the properties of an organ, such as organ structure and function. Also, organoids can restore a tissue or organ's original genetic and epigenetic state, making them suitable for gene editing. Various studies have shown positive results of combining CRISPR-Cas9 technology with organoids, which has expanded opportunities for breakthroughs in cystic fibrosis. According to a study 'CRISPR-Based Adenine Editors Correct Nonsense Mutations in a Cystic Fibrosis Organoid Biobank,' published in 2020, a biobank of cystic fibrosis intestinal organoids represented 664 patients, and ~20% of them were theoretically able to efficiently repair nonsense mutations in the cystic fibrosis transmembrane conductor receptor through adenine base editors. Despite a few achievements of gene-edited organoids in some animal models, their efficiency is significantly low, and the success rate is not high. Therefore, it is crucial to research and develop a process for gene-edited organoids' safety, long-term stability, and functionality.

Moreover, the COVID-19 pandemic triggered the need to develop human lung organoid models. For instance, MilliporeSigma developed a 3dGRO Human Lung Organoid Culture System that allows researchers to control, access, and reproduce organ tissue for culturing an organoid model of human lung epithelium that can aid in obtaining positive and successful results during their research. Thus, such innovations are expected to offer more significant growth opportunities for the market growth.

Asia Pacific Organoids Market Overview

The Asia Pacific organoids market is segmented into Australia, China, India, Japan, South Korea, and the Rest of Asia Pacific. The market in the region is likely to continue to grow at the fastest rate during the forecast period owing to factors such as increasing incidences of cancer, growing demand for gene mutation and cancer research, government efforts to raise awareness related to human organoids, supportive regulations for the development and commercialization of advanced human organoids products, and increased funding for organoids research.

Asia Pacific Organoids Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Organoids Market Segmentation

The Asia Pacific organoids market is segmented into organ type, type application, source, and country.

Based on organ type, the Asia Pacific organoids market is segmented into intestine, liver, stomach, pancreas, lung, brain, kidney, and others. The intestine segment held the largest share of the Asia Pacific organoids market in 2022.

Based on type, the Asia Pacific organoids market is segmented into instruments, consumables, and services. The consumables segment held the largest share of the Asia Pacific organoids market in 2022.

Based on application, the Asia Pacific organoids market is segmented into developmental biology disease, pathology of infectious disease, regenerative medicine, drug toxicity and efficacy testing, drug discovery and personalized medicine, and others. The developmental biology disease segment held largest share of the Asia Pacific organoids market in 2022.

Based on source, the Asia Pacific organoids market is bifurcated into pluripotent stem cells and organ-specific adult stem cell. The pluripotent stem cells segment held a larger share of the Asia Pacific organoids market in 2022.

Based on country, the Asia Pacific organoids market is segmented into the Japan, China, Australia, India, South Korea, and the Rest of Asia Pacific. Japan dominated the Asia Pacific organoids market in 2022.

Cellesce, Corning Inc, InSphero, Merck KGaA, STEMCELL Technologies Inc, and Thermo Fisher Scientific Inc are some of the leading companies operating in the Asia Pacific organoids market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific organoids market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in Asia Pacific organoids market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Asia Pacific Key Insights
  • 2.2 Asia Pacific Market Attractiveness

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific Organoids Market Landscape

  • 4.1 Overview
  • 4.2 Asia Pacific PEST Analysis

5. Asia Pacific Organoids Market - Key Industry Dynamics

  • 5.1 Key Market Drivers:
    • 5.1.1 Increasing Demand for Tumor Modeling and Biobanking
    • 5.1.2 Growing Adoption of Personalized Drugs
    • 5.1.3 Rising Focus on Developing Alternatives for Animal Testing Models
  • 5.2 Key Market Restraints:
    • 5.2.1 Issues Related to Incorporation of Organoids into Existing Workflows
    • 5.2.2 Dearth of Skilled Professionals
  • 5.3 Key Market Opportunities:
    • 5.3.1 Focus on Drug Discovery Activities
  • 5.4 Future Trends:
    • 5.4.1 Combining Organoid with Organ-On-A-Chip
  • 5.5 Impact Analysis:

6. Organoids Market - Asia Pacific Market Analysis

  • 6.1 Asia Pacific Organoids Market Revenue (US$ Mn), 2022 - 2030

7. Asia Pacific Organoids Market - Revenue and Forecast to 2030 - by Type

  • 7.1 Overview
  • 7.2 Asia Pacific Organoids Market Revenue Share, by Organ Type 2022 & 2030 (%)
  • 7.3 Stomach
    • 7.3.1 Overview
    • 7.3.2 Stomach: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Intestine
    • 7.4.1 Overview
    • 7.4.2 Intestine: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Liver
    • 7.5.1 Overview
    • 7.5.2 Liver: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Pancreas
    • 7.6.1 Overview
    • 7.6.2 Pancreas: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Lung
    • 7.7.1 Overview
    • 7.7.2 Lung: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.8 Brain
    • 7.8.1 Overview
    • 7.8.2 Brain: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.9 Kidney
    • 7.9.1 Overview
    • 7.9.2 Kidney: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.10 Others
    • 7.10.1 Overview
    • 7.10.2 Others: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Organoids Market - Revenue and Forecast to 2030 - by Application

  • 8.1 Overview
  • 8.2 Asia Pacific Organoids Market Revenue Share, by Application 2022 & 2030 (%)
  • 8.3 Developmental Biology
    • 8.3.1 Overview
    • 8.3.2 Developmental Biology: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Disease Pathology of Infectious Disease
    • 8.4.1 Overview
    • 8.4.2 Disease Pathology of Infectious Disease: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Regenerative Medicine
    • 8.5.1 Overview
    • 8.5.2 Regenerative Medicine: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Drug Toxicity and Efficacy Testing
    • 8.6.1 Overview
    • 8.6.2 Drug Toxicity and Efficacy Testing: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Drug Discovery and Personalized Medicine
    • 8.7.1 Overview
    • 8.7.2 Drug Discovery and Personalized Medicine: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.8 Others
    • 8.8.1 Overview
    • 8.8.2 Others: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Organoids Market - Revenue and Forecast to 2030 - by Source

  • 9.1 Overview
  • 9.2 Asia Pacific Organoids Market Revenue Share, by Source 2022 & 2030 (%)
  • 9.3 Pluripotent Stem Cells
    • 9.3.1 Overview
    • 9.3.2 Pluripotent Stem Cells: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Organ-specific Adult Stem Cells
    • 9.4.1 Overview
    • 9.4.2 Organ-specific Adult Stem Cells: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Organoids Market - Revenue and Forecast to 2030 - by Type

  • 10.1 Overview
  • 10.2 Asia Pacific Organoids Market Revenue Share, by Type 2022 & 2030 (%)
  • 10.3 Instruments
    • 10.3.1 Overview
    • 10.3.2 Instruments: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.4 Consumables
    • 10.4.1 Overview
    • 10.4.2 Consumables: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.5 Services
    • 10.5.1 Overview
    • 10.5.2 Services: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)

11. Asia Pacific Organoids Market - Country Analysis

  • 11.1 Asia Pacific Organoids Market, Revenue and Forecast to 2030
    • 11.1.1 Overview
    • 11.1.2 Asia Pacific Organoids Market by Country
      • 11.1.2.1 China
        • 11.1.2.1.1 Overview
        • 11.1.2.1.2 China Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.2.1.3 China Organoids Market, by Organ Type
        • 11.1.2.1.4 China Organoids Market, by Application
        • 11.1.2.1.5 China Organoids Market, by Source
        • 11.1.2.1.6 China Organoids Market, by Type
      • 11.1.2.2 Japan
        • 11.1.2.2.1 Overview
        • 11.1.2.2.2 Japan Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.2.2.3 Japan Organoids Market, by Organ Type
        • 11.1.2.2.4 Japan Organoids Market, by Application
        • 11.1.2.2.5 Japan Organoids Market, by Source
        • 11.1.2.2.6 Japan Organoids Market, by Type
      • 11.1.2.3 India
        • 11.1.2.3.1 Overview
        • 11.1.2.3.2 India Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.2.3.3 India Organoids Market, by Organ Type
        • 11.1.2.3.4 India Organoids Market, by Application
        • 11.1.2.3.5 India Organoids Market, by Source
        • 11.1.2.3.6 India Organoids Market, by Type
      • 11.1.2.4 Australia
        • 11.1.2.4.1 Overview
        • 11.1.2.4.2 Australia Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.2.4.3 Australia Organoids Market, by Organ Type
        • 11.1.2.4.4 Australia Organoids Market, by Application
        • 11.1.2.4.5 Australia Organoids Market, by Source
        • 11.1.2.4.6 Australia Organoids Market, by Type
      • 11.1.2.5 South Korea
        • 11.1.2.5.1 Overview
        • 11.1.2.5.2 South Korea Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.2.5.3 South Korea Organoids Market, by Organ Type
        • 11.1.2.5.4 South Korea Organoids Market, by Application
        • 11.1.2.5.5 South Korea Organoids Market, by Source
        • 11.1.2.5.6 South Korea Organoids Market, by Type
      • 11.1.2.6 Rest of Asia Pacific
        • 11.1.2.6.1 Overview
        • 11.1.2.6.2 Rest of Asia Pacific Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.2.6.3 Rest of Asia Pacific Organoids Market, by Organ Type
        • 11.1.2.6.4 Rest of Asia Pacific Organoids Market, by Application
        • 11.1.2.6.5 Rest of Asia Pacific Organoids Market, by Source
        • 11.1.2.6.6 Rest of Asia Pacific Organoids Market, by Type

12. Pre & Post COVID-19 Impact

  • 12.1 Pre & Post COVID-19 Impact

13. Asia Pacific Organoids Market Industry Landscape

  • 13.1 Overview
  • 13.2 Growth Strategies Done by the Companies in the Market, (%)
  • 13.3 Organic Developments
    • 13.3.1 Overview
  • 13.4 Inorganic Developments
    • 13.4.1 Overview

14. Asia Pacific Organoids Market, Key Company Profiles

  • 14.1 STEMCELL Technologies Inc.
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Cellesce Ltd
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 Thermo Fisher Scientific Inc
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 Corning Inc
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 Merck KGaA
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 InSphero
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Products and Services
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments

15. Appendix

  • 15.1 About Us
  • 15.2 Glossary of Terms